Real-time enrollment status for this pancreatic adenocarcinoma non-resectable clinical trial
Current Status
Recruiting
Checked: August 30, 2026 at 5:47 PM UTC
| NCT Number | NCT07481383 |
| Recruiting Status | Recruiting |
| Condition | Pancreatic Adenocarcinoma Non-resectable |
| Phase | PHASE1 |
| Target Enrollment | 12 participants |
| Active Locations | 2 sites in the US |
| Sponsor | Continuity Biosciences, LLC |
| Last Updated on CT.gov | July 6, 2026 (Jul 6, 2026) |
As of August 30, 2026: Clinical trial NCT07481383 is currently recruiting participants. This phase1 study for pancreatic adenocarcinoma non-resectable is actively seeking new participants at 2 locations across the United States. The study is sponsored by Continuity Biosciences, LLC. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07481383 is actively recruiting participants as of August 30, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07481383 was last updated Jul 6, 2026 (July 6, 2026). HelloStudys verifies this status automatically.